Academic Journal
1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3
العنوان: | 1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3 |
---|---|
المؤلفون: | Sulkowski, M., Gardiner, D., Lawitz, E., Hinestrosa, F., Nelson, D., Thuluvath, P., Rodriguez-Torres, M., Lok, A., Schwartz, H., Reddy, K.R., Eley, T., Wind-Rotolo, M., Huang, S.-P., Gao, M., McPhee, F., Hindes, R., Symonds, B., Pasquinelli, C., Grasela, D. |
المصدر: | Journal of Hepatology ; volume 56, page S560 ; ISSN 0168-8278 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2012 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/s0168-8278(12)61433-0 |
الاتاحة: | http://dx.doi.org/10.1016/s0168-8278(12)61433-0 https://api.elsevier.com/content/article/PII:S0168827812614330?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0168827812614330?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ |
رقم الانضمام: | edsbas.38588F97 |
قاعدة البيانات: | BASE |
DOI: | 10.1016/s0168-8278(12)61433-0 |
---|